personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
In this month’s issue of The Small Molecule Manufacturer, we explore how pharma companies are working to improve pediatric drug formulations. Guia Bertuzzi, Product Manager for Granulation at IMA Active, Italy, argues that companies must choose granulation machinery that will stand the test of time while meeting their QbD and PAT requirements in Inside the Medicine Machine. In addition, we find out how pharmaceutical companies can use digital technologies to their advantage amidst the COVID-19 pandemic, and speak to Tom Moody, VP of Technology Development and Commercialization at Almac, UK, about his career spent striving for pharmaceutical and cross-disciplinary excellence.